EWPHE Conclusions Active treatment reduced cardiovascular (CV) mortality, largely due to a reduction in cardiac mortality Older patients (>60 yrs old)
{"Image DocumentName": "EWPHE ConclusionsActive treatment reduced cardiovascular (CV) mortality, largely due to a reduction in cardiac mortality.", "Image ImageDescription": "Older patients (>60 yrs old) with combined systolic and diastolic hypertension who received active therapy experienced 29 fewer CV events and 14 fewer CV deaths per 1,000 patient-years of treatment. EWPHE Conclusions. Active treatment in EWPHE reduced risk for fatal cardiovascular (CV) events, largely due to a reduction in cardiac events. Older patients with combined systolic and diastolic hypertension who received active therapy experienced 29 fewer CV events and 14 few CV deaths per 1,000 patient-years of treatment. Reference: Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet Jun 15;1(8442): EWPHE=European Working Party on High Blood Pressure in the Elderly. Amery A, et al. Lancet. 1985;1:", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}